Pfizer submits vitiligo data for oral drug approval
Pfizer submits oral drug Litfulo data for nonsegmental vitiligo approval, a condition affecting about 70 million people worldwide.
AI Could Help Social Care But Won’t Replace Human Judgment
AI could improve social care by connecting fragmented systems and flagging risks, but it will not replace the human elements…
FDA clears DreaMed’s CGM-based insulin dosing tool
FDA clears DreaMed’s MODI system, the first CGM-based tool for automated insulin dosing in Type 2 diabetes patients using multiple…
Doctors Remain Liable for AI Mistakes in Healthcare
AI liability in healthcare raises concerns as doctors may be held responsible for mistakes made by decision-support tools, prompting tighter…
ADARx Raises $535M in IPO for RNA-Targeted Therapies
ADARx raises $535M in IPO for RNA-targeted therapies, advancing siRNA-based treatments to degrade disease-causing proteins.
Patients Use AI Assistants to Record Doctor Visits
Patients use AI assistants to record doctor visits and reconstruct conversations for better follow-up care.
Startup raises $22M to expand at-home HPV screening
Teal Health raises $22M to expand its FDA-authorized at-home HPV screening device, offering self-collection and telehealth follow-up for cervical cancer…
Oncologists Adopt AI Potential, But Few Use Predictive Models
Oncologists recognize AI's potential to enhance cancer care, yet only 19% utilize predictive models, revealing a significant implementation gap.
AI lacks key connectivity layer
AI lacks key connectivity layer for accurate data records connection to individuals, hindering analysis and modeling efforts.
Breast MRI Approved But Insurance Won’t Pay
Breast MRI is medically approved but often not covered by insurance. Learn about Stephanie Halver's experience and the reimbursement challenges.